#VisualAbstract: Ibrutinib-Venetoclax Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

Susie Wiles’ breast cancer diagnosis drives national screening surge

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

#VisualAbstract: Ibrutinib-Venetoclax Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

Susie Wiles’ breast cancer diagnosis drives national screening surge

Current expert consensus for the treatment of adult patients with drug reaction with eosinophilia and systemic symptoms

Concurrent strength and endurance training in females increases parameters associated with maximal strength and endurance capacity

RelatedReports

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

Susie Wiles’ breast cancer diagnosis drives national screening surge

Delaying pegfilgrastim administration reduces bone pain in breast cancer patients

Concurrent strength and endurance training in females increases parameters associated with maximal strength and endurance capacity

Low income associated with worse cardiovascular health in middle-aged adults

#VisualAbstract: Low-dose amitriptyline effective and well-tolerated for management of irritable bowel syndrome

Recent Reports